Канада - англійська - Health Canada

apotex inc - fluticasone propionate - aerosol, metered dose - 50mcg - fluticasone propionate 50mcg

Канада - англійська - Health Canada

mylan pharmaceuticals ulc - fluticasone propionate; azelastine hydrochloride - spray, metered dose - 50mcg; 137mcg - fluticasone propionate 50mcg; azelastine hydrochloride 137mcg

Ізраїль - англійська - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - powder for inhalation - fluticasone propionate 500 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma.fluticasone propionate is indicated for the management of copd when used in combination with long-acting bronchodilators (e.g. long-acting beta agonists (labas)).

Ізраїль - англійська - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - powder for inhalation - fluticasone propionate 250 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma.fluticasone propionate is indicated for the management of copd when used in combination with long-acting bronchodilators (e.g. long-acting beta agonists (labas)).

Ізраїль - англійська - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - powder for inhalation - fluticasone propionate 50 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma.

Ізраїль - англійська - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - suspension for inhalation - fluticasone propionate 250 mcg/dose - fluticasone - fluticasone - prophylactic management of all grades of asthma.fluticasone propionate is indicated for the management of copd when used in combination with long-acting bronchodilators (e.g. long-acting beta agonists (labas)).

Ізраїль - англійська - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - suspension for inhalation - fluticasone propionate 125 mcg/dose - fluticasone - fluticasone - prophylactic management of all grades of asthma.

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

fannin (uk) ltd - salmeterol - pressurised inhalation, suspension - 25 microgram(s) - selective beta-2-adrenoreceptor agonists; salmeterol

США - англійська - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - salmeterol xinafoate (unii: 6ew8q962a5) (salmeterol - unii:2i4bc502bt), fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - salmeterol 50 ug - advair diskus is indicated for the treatment of asthma in patients aged 4 years and older. long-acting beta2 -adrenergic agonists (labas), such as salmeterol, one of the active ingredients in advair diskus, increase the risk of asthma-related death. available data from controlled clinical trials suggest that labas increase the risk of asthma-related hospitalization in pediatric and adolescent patients [see warnings and precautions (5.1)] . therefore, when treating patients with asthma, physicians should only prescribe advair diskus for patients not adequately controlled on a long-term asthma control medication, such as an inhaled corticosteroid, or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a laba. once asthma control is achieved and maintained, assess the patient at regular intervals and step down therapy (e.g., discontinue advair diskus) if possible without loss of asthma control and maintain the patient on a long-term asthma control medication, s

США - англійська - NLM (National Library of Medicine)

dispensing solutions inc. - salmeterol xinafoate (unii: 6ew8q962a5) (salmeterol - unii:2i4bc502bt), fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - salmeterol xinafoate 50 ug - advair diskus is indicated for the long-term, twice-daily, maintenance treatment of asthma in patients aged 4 years and older. long-acting beta2 -adrenergic agonists, such as salmeterol, one of the active ingredients in advair diskus, may increase the risk of asthma-related death [see warnings and precautions (5.1)] . therefore, when treating patients with asthma, physicians should only prescribe advair diskus for patients not adequately controlled on other asthma-controller medications (e.g., low- to medium-dose inhaled corticosteroids) or whose disease severity clearly warrants initiation of treatment with 2 maintenance therapies. important limitations of use: - advair diskus is not indicated for the relief of acute bronchospasm. - advair diskus is not indicated in patients whose asthma can be successfully managed by inhaled corticosteroids along with occasional use of inhaled, short-acting beta2 -agonists. advair diskus 250/50 is indicated for the twice-daily maintenance treatment of airflow obstruction in